• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Senate committee advances nomination of Dr Oz to run Centers for Medicare and Medicaid Services

by March 25, 2025
written by March 25, 2025

The Senate Committee on Finance voted along party lines Tuesday afternoon to advance Dr. Mehmet Oz, President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, to a full confirmation vote. 

The party-line vote, which saw 14 GOP senators vote in favor of Oz’s nomination and 13 Democrats vote against it, follows two hearings by the Senate Finance Committee that probed Oz over his plans for the federal healthcare programs, his views on abortion, potential conflicts of interest in the healthcare industry and more.

‘Dr. Oz has years of experience as an acclaimed physician and public health advocate. His background makes him uniquely qualified for this role, and there is no doubt that he will work tirelessly to deliver much-needed change at CMS,’ Sen. Mike Crapo, R-Idaho, the chairman of the committee, said Tuesday. 

Oz graduated from Harvard University and received medical and business degrees from the University of Pennsylvania. He is a former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show.’

Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. 

If confirmed by the full Senate, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

Oz’s leadership would direct decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services.

Earlier this month, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were also approved in committee and are awaiting full confirmation votes in the Senate scheduled for later Tuesday. It is unclear when Oz’s full Senate vote will take place.

Around the same time that Bhattacharya and Makary won committee approval, Trump withdrew his nomination of former Florida Rep. David Weldon to run the CDC, over fears he did not have the GOP support to clear full confirmation. On Monday, the Trump administration named Susan Monarez, acting director of the CDC, as its new nominee.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump pardons former Hunter Biden business associate Devon Archer
next post
Trump’s pick to lead NIH, Dr. Jay Bhattacharya, confirmed by Senate in party-line vote

related articles

Inside Trump’s ultimatum that forced Netanyahu to the...

October 23, 2025

Vance rebukes Israel on ‘very stupid’ vote to...

October 23, 2025

Top Republican slams Katherine Clark for admitting suffering...

October 23, 2025

Vance calls Psaki comments about wife Usha ‘disgraceful’

October 23, 2025

Trump yet to endorse in VA governor’s race...

October 23, 2025

DAVID MARCUS: Trump’s ballroom is no vanity project,...

October 23, 2025

Examining the next threat from Communist China: Our...

October 23, 2025

Sparks fly as Cuomo, Mamdani tear into each...

October 23, 2025

Trump meets NATO’s Rutte amid canceled Putin meeting:...

October 22, 2025

Schumer blocks 12th GOP bid to reopen government...

October 22, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Space-based missile-killing Golden Dome tech aims for crucial test before Trump leaves office: Lockheed Martin

    August 6, 2025
  • KJP says President Biden still has no plans to pardon Hunter Biden for tax fraud, gun charges

    November 8, 2024
  • What Trump’s Nvidia and AMD China deal means for the world

    August 12, 2025
  • Trump’s ‘two sexes’ executive order comes on heels of SCOTUS accepting another challenge to LGBT agenda

    January 25, 2025
  • Tesla is the new meme stock, according to one billionaire investor

    July 11, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,503)
  • Investing (634)
  • Stock (941)

Latest Posts

  • The S&P 500 and Nasdaq retreated to new lows yesterday

    October 2, 2024
  • Israel says it killed Iranian commander who helped fund, arm Hamas

    June 21, 2025
  • Europe must invoke ‘snapback’ sanctions on Iran, US lawmakers say, as Trump resumes ‘maximum pressure’

    February 13, 2025

Recent Posts

  • Homesick GOP senators mull throwing out the rules over stonewalling Dems

    July 31, 2025
  • Trump defends Qatar jumbo jet offer as troubled Boeing fails to deliver new Air Force One fleet

    May 12, 2025
  • Israel bans UN secretary-general over anti-Israel actions: ‘Doesn’t deserve to set foot on Israeli soil’

    October 2, 2024

Editor’s Pick

  • ApeCoin and Akita Inu: ApeCoin drops to a new low on Monday

    October 1, 2024
  • Trump to formally accept Republican presidential nomination in speech altered after assassination attempt

    July 18, 2024
  • Pentagon may sink Biden-era deal to sell Australia nuclear-powered submarines

    June 12, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock